GL0034 (Utreglutide), a novel, long acting, glucagon-like peptide 1 receptor agonist (GLP-1 RA), results of a phase 1 study in healthy individuals

被引：0
|
作者：
Thennati, Rajamannar [1 ]
Burade, Vinod [1 ]
Natarajan, Muthukumaran [1 ]
Shahi, Pradeep [1 ]
Nagaraja, Ravishankara [1 ]
Panchal, Satish [1 ]
Agrawal, Sudeep [1 ]
Jandrain, Bernard [2 ]
Duvauchelle, Thierry [3 ]
Pratley, Richard E. [4 ]
Thorens, Bernard [5 ]
Vilsboll, Tina [6 ]
机构：
[1] Sun Pharmaceut Ind Ltd, High Impact Innovat Sustainable Hlth Solut HISHS, Vadodara, India
[2] Acad Hosp Liege, ATC Co, Clin Pharmacol Unit, Nutr & Metab Disorders, Liege, Belgium
[3] Phaster1, Paris, France
[4] AdventHlth Translat Res Inst, Orlando, FL USA
[5] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland
[6] Univ Copenhagen, Steno Diabet Ctr, Clin Res, Copenhagen, Denmark
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-419
引用
收藏
页码：S607 / S608
页数：2
相关论文
共 50 条
  • [21] Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes
    Nauck, MA
    HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) : 852 - 858
  • [22] Glucagon-like peptide 1 (GLP-1) and metabolic diseases
    C. M. Rotella
    L. Pala
    E. Mannucci
    Journal of Endocrinological Investigation, 2005, 28 : 746 - 758
  • [23] Once Weekly Utreglutide (GL0034), a Glucagon-like Peptide-1 Receptor Agonist, at 4 x 450 μg Doses Reduces Blood Pressure, Lipids, and Body Weight in Post-menopausal Females: A Phase I Study
    Thennati, Rajamannar
    Burade, Vinod
    Natarajan, Muthukumaran
    Shahi, Pradeep
    Nagaraja, Ravishankara
    Agrawal, Sudeep
    Duvauchelle, Thierry
    Pratley, Richard
    Thorens, Bernard
    Vilsboll, Tina
    CIRCULATION, 2024, 150
  • [24] Glucagon-like peptide 1(GLP-1) in biology and pathology
    Meier, JJ
    Nauck, MA
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (02) : 91 - 117
  • [25] Glucagon-like peptide 1 (GLP-1) in diabetes and aging
    D'Alessio, D
    JOURNAL OF ANTI-AGING MEDICINE, 2000, 3 (03): : 329 - 333
  • [26] Miglitol treatment releases glucagon-like peptide 1 (GLP-1) in healthy volunteers
    Hodel, P
    Varga, L
    Göke, B
    DIABETOLOGIA, 2000, 43 : A183 - A183
  • [27] ALBIGLUTIDE Glucagon-Like Peptide GLP-1 Receptor Agonist Treatment of Type 2 Diabetes
    Rosenstock, Julio
    Stewart, Murray W.
    DRUGS OF THE FUTURE, 2010, 35 (09) : 701 - 712
  • [28] Novel GLP-1 Fusion Chimera as Potent Long Acting GLP-1 Receptor Agonist
    Wang, Qinghua
    Chen, Kui
    Liu, Rui
    Zhao, Fang
    Gupta, Sandeep
    Zhang, Nina
    Prud'homme, Gerald J.
    PLOS ONE, 2010, 5 (09): : 1 - 9
  • [29] An audit of the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide: use over 5 years
    Johns, E.
    McArdle, K.
    Carty, D.
    Kernohan, A.
    DIABETIC MEDICINE, 2015, 32 : 112 - 112
  • [30] Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor
    Helmstaedter, Johanna
    Keppeler, Karin
    Kuester, Leonie
    Muenzel, Thomas
    Daiber, Andreas
    Steven, Sebastian
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 659 - 676
12345